Ledger.Open graph →
SEC Form D · filed July 11, 2014

Sprout Pharmaceuticals, Inc

Offering
$15.0M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Matthew J. Graver · WEST CONSHOHOCKEN, PAExecDima E. Skvortsov · WEST CONSHOHOCKEN, PADirectorNeha D. Markle · WEST CONSHOHOCKEN, PAExec · DirectorDavid A. Wilton · WEST CONSHOHOCKEN, PADirectorVictoria A. Eckstein · WEST CONSHOHOCKEN, PAExec · DirectorSheri L. Schreck · WEST CONSHOHOCKEN, PAExecRobert J. Creaney · WEST CONSHOHOCKEN, PAExec · DirectorEdward J. Goldstein · WEST CONSHOHOCKEN, PAExec · DirectorRyan A. Meredith · WEST CONSHOHOCKEN, PAExec · DirectorTimothy J. Knierim · WEST CONSHOHOCKEN, PAExecSteven A. Shin · WEST CONSHOHOCKEN, PAExec · DirectorAndrew J. Murray · WEST CONSHOHOCKEN, PADirectorPatrick A. Reid · WEST CONSHOHOCKEN, PADirectorDebbra L. Schoneman · Minneapolis, MNExecMelissa J. Kang · WEST CONSHOHOCKEN, PADirectorRobert W. Dahl · Raleigh, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗